Revealing the path of a metallodrug in a breast cancer cell
(PHYSorg.com Chemistry)

Some types of cancer cannot be treated with classical chemotherapy. Scientists from Inserm, CNRS, Sorbonne University, PSL university, University Grenoble Alpes and ESRF, the European Synchrotron, are working on a metallorganic molecule as an antitumor drug. Their research has produced thorough insights into its mechanism in attacking cancer cells. This study is published in Angewandte Chemie.